Veru completes enrollment of obesity drug trial with 239 patients
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
More in Health & Medicine
GP found guilty of misconduct over Covid social posts
A Wexford GP has been found guilty of professional misconduct over posts on social media during the Covid-19 pandemic which were highly critical of public health measures introduced to tackle the…
Researchers help identify new Ebola variant and potential treatment
When the World Health Organization declared an Ebola outbreak in Uganda and the Democratic Republic of the Congo (DRC) a Public Health Emergency of International Concern in May, scientists around the…
Silence spells out Phase 2 success for gene-silencing drug in rare blood cancer
Silence Therapeutics is set to advance its siRNA drug for the rare blood disorder polycythemia vera (PV) into Phase 3 following a successful mid-stage trial.
STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer
A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine.
With ‘The Galloping Cure’ in Edinburgh, Missy Mazzoli Tackles the Opioid Crisis
The composer Missy Mazzoli, driven by personal loss, has turned America’s overdose epidemic into a dark, fantastical allegory.
Early-Life Stress Leaves Epigenetic “Scars” That Prime Stress Sensitivity
Scientists linked early-life stress experience in mice to long-term stress hypersensitivity within the brain’s dopaminergic circuitry, providing a mechanism by which early-life stress increases risk…